Published September 15, 2021
| Version v1
Other
Open
Supplement to LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia
Description
Supplemental information to the manuscript entitled "LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults with Modest Hypertriglyceridemia"
Files
JCLINENDOMETAB-S-21-015424 R1 Supplement.pdf
Files
(391.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:007a04643cb674af89ca7f7d2c3a137e
|
391.1 kB | Preview Download |
Additional details
References
- Rader DJ, Maratos-Flier E, Nguyen A, Hom D, Ferriere M, Li Y, Kompa J, Martic M, Hinder M, Basson CT, Yowe D, Diener J, Goldfine AB; CLLF580X2102 study team. LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia. J Clin Endocrinol Metab. 2021 Aug 25:dgab624. doi: 10.1210/clinem/dgab624. Epub ahead of print. PMID: 34431493.